4.6 Article

miR-29a-3p directly targets Smad nuclear interacting protein 1 and inhibits the migration and proliferation of cervical cancer HeLa cells

Related references

Note: Only part of the references are listed.
Review Biochemistry & Molecular Biology

The role of miRNAs in the invasion and metastasis of cervical cancer

Jin-yan Wang et al.

BIOSCIENCE REPORTS (2019)

Article Biochemistry & Molecular Biology

Overexpression of miR-335 inhibits the migration and invasion of osteosarcoma by targeting SNIP1

Yuanlong Xie et al.

INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES (2019)

Article Biotechnology & Applied Microbiology

MiR-29a function as tumor suppressor in cervical cancer by targeting SIRT1 and predict patient prognosis

Ping Nan et al.

ONCOTARGETS AND THERAPY (2019)

Review Biochemistry & Molecular Biology

MiR-29a: a potential therapeutic target and promising biomarker in tumors

Jin-yan Wang et al.

BIOSCIENCE REPORTS (2018)

Article Biochemistry & Molecular Biology

MicroRNA-29a Alleviates Bile Duct Ligation Exacerbation of Hepatic Fibrosis in Mice through Epigenetic Control of Methyltransferases

Ya-Ling Yang et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)

Review Oncology

Small non-coding RNA and cancer

Giulia Romano et al.

CARCINOGENESIS (2017)

Article Biochemistry & Molecular Biology

MiR-29a promotes cell proliferation and EMT in breast cancer by targeting ten eleven translocation 1

Yao-fei Pei et al.

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2016)

Review Oncology

Advances in diagnosis and treatment of metastatic cervical cancer

Haoran Li et al.

JOURNAL OF GYNECOLOGIC ONCOLOGY (2016)

Article Biotechnology & Applied Microbiology

MicroRNA-29a plays a suppressive role in non-small cell lung cancer cells via targeting LASP1

Zhaolan Hu et al.

ONCOTARGETS AND THERAPY (2016)

Article Medicine, General & Internal

Improved Survival with Bevacizumab in Advanced Cervical Cancer

Krishnansu S. Tewari et al.

NEW ENGLAND JOURNAL OF MEDICINE (2014)

Review Pathology

New Roles of Cyclin D1

Richard G. Pestell

AMERICAN JOURNAL OF PATHOLOGY (2013)

Article Cell Biology

SNIP1: a new activator of HSE signaling pathway

Qiang Li et al.

MOLECULAR AND CELLULAR BIOCHEMISTRY (2012)

Article Medicine, General & Internal

Breast and cervical cancer in 187 countries between 1980 and 2010: a systematic analysis

Mohammad H. Forouzanfar et al.

LANCET (2011)

Article Medicine, Research & Experimental

Silencing Heat Shock Protein 27 Decreases Metastatic Behavior of Human Head and Neck Squamous Cell Cancer Cells in Vitro

Zhenkun Zhu et al.

MOLECULAR PHARMACEUTICS (2010)

Article Biochemistry & Molecular Biology

miR-29 miRNAs activate p53 by targeting p85a and CDC42

Seong-Yeon Park et al.

NATURE STRUCTURAL & MOLECULAR BIOLOGY (2009)

Article Oncology

Regulation of cyclin D1 RNA stability by SNIP1

Cameron P. Bracken et al.

CANCER RESEARCH (2008)

Article Multidisciplinary Sciences

The FHA domain proteins DAWDLE in Arabidopsis and SNIP1 in humans act in small RNA biogenesis

Bin Yu et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)

Article Biochemistry & Molecular Biology

SNIP1 is a candidate modifier of the transcriptional activity of c-Myc on E box-dependent target genes

Makiko Fujii et al.

MOLECULAR CELL (2006)

Review Biochemistry & Molecular Biology

MicroRNAs: Genomics, biogenesis, mechanism, and function

DP Bartel

Article Biochemistry & Molecular Biology

The FHA domain protein SNIP1 is a regulator of the cell cycle and cyclin D1 expression

KC Roche et al.

ONCOGENE (2004)

Article Biochemistry & Molecular Biology

SNIP1 inhibits NF-κB signaling by competing for its binding to the C/H1 domain of CBP/p300 transcriptional Co-activators

RH Kim et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2001)